T he cardiac Na-Ca exchanger (NCX), a protein found in the sarcoplasmic membrane, acts as the major Ca 2ϩ efflux path and is an important Ca 2ϩ handling protein regulating intracellular Ca 2ϩ in excitation-contraction coupling in the heart. The NCX plays an important role in pathological states as well, acting as a major Ca 2ϩ entry site during ischemia/reperfusion. 1 In heart failure (HF), the NCX is significantly upregulated in both human 2 and animal models, 3, 4 which may significantly impair cardiac contractility by reducing sarcoplasmic reticular Ca 2ϩ content via premature Ca 2ϩ efflux. 5 It may also promote unstable repolarization with early and/or delayed afterdepolarizations, triggering fatal ventricular arrhythmias. 6 
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Cardiac output is controlled on a beat-to-beat basis by the interaction of the sympathetic and parasympathetic nervous systems. Cardiac sympathetic stimulation activates the ␤-adrenergic receptor (␤-AR), whereas parasympathetic stimulation acts on cardiac muscarinic receptor (M-2) systems. These signaling systems interact to regulate cardiac contractility and rate by modulating critical effector proteins 7 via "accentuated antagonism," 8 a phenomenon in which the effect of sympathetic stimulation is rapidly reversed by parasympathetic stimulation despite continued application of the initial stimulus. Accentuated antagonism allows rapid increases in cardiac output in response to physiological challenge while preventing toxicity from excess adrenergic tone. 9 In HF both ␤-AR and M-2 cardiac responsiveness are depressed, contributing to lost cardiac reserve, increased arrhythmic susceptibility, 10 and death. However, the underlying cellular mechanism of these phenomena is far from clear. Some studies have attributed this loss of autonomic responsiveness to the desensitization of ␤-AR receptors and/or downregulation of signal transduction in HF. 11, 12 However, recent work suggests that the L-type Ca 2ϩ channel and ryanodine receptor are tonically phosphorylated ("hyperphosphorylated") at baseline in failing human myocytes, [13] [14] [15] [16] which could contribute to depressed ␤-AR responsiveness in cardiac function in HF. Some investigators, but not all, have suggested that the NCX is regulated by ␤-AR [17] [18] [19] and M-2 systems. 20 Schulze et al 21 reported that the NCX in heart is found in a macromolecular complex containing protein kinase A (PKA), protein kinase C, and the protein phosphatases PP1 and PP2a. We recently reported that the NCX current in HF was increased in the basal state, 22 manifesting blunted ␤-AR regulation, and that these alterations are due to NCX hyperphosphorylation in HF. 23 The effect of hyperphosphorylation on the muscarinic modulation of the affected proteins has not been investigated previously. In the present study, we investigated ␤-AR and M-2 regulation of the NCX in both control and HF states using a pacing-induced failing pig model. Our new model is similar to that reported previously except that the present study was performed in atrially (as opposed to ventricularly) paced animals. Rapid atrial pacing results in ventricular dilatation, neurohormonal activation, and loss of ␤-AR responsiveness similar to other HF models. 24, 25 The change in protocol was introduced for the following reasons: ventricular pacing bypasses the His-Purkinje conduction system and alters the normal pattern of ventricular depolarization, whereas atrial pacing does not (in the absence of conduction system disease). 26 Altered ventricular depolarization has numerous effects on cellular protein expression, including the distribution of gap junctions 27 and NCX protein density (David Rosenbaum, MD, PhD, personal communication, June 6, 2005) . Ventricular pacing per se may introduce phenotypic changes in ventricular myocytes that confound our ability to assess the effect of HF. Additionally, ventricular pacing causes significant changes in ventricular repolarization, preventing a meaningful assessment of the impact of HF on the surface ECG and T wave. Using our refined HF model, we found that in HF the NCX was highly active and displayed markedly depressed ␤-AR and M-2 responsiveness. The common pathway of these alterations is downregulation of protein phosphatase expression and activity associated with the NCX, resulting in defective NCX dephosphorylation in HF.
Methods

Pacing-Induced Pig HF Model
Induction of HF and ventricular cardiomyocyte isolation and culture were performed as described previously, 22, 23 with the use of protocols approved by the university's Institutional Animal Care and Use Committee, except that the animals were atrially rather than ventricularly paced. The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). In brief, Yorkshire pigs (Animal Biotech Industries, Danboro, Pa) of either sex were anesthetized with thiopental sodium (10 mg/kg IV) to allow tracheal intubation and then maintained with isoflurane. The right external jugular vein was isolated and cannulated. An active-fixation pacing lead was advanced under fluoroscopy to the right atrial appendage. Adequate positioning was confirmed by pacing threshold and P-wave sensing, and the lead was sutured to underlying fascia. After 24 to 48 hours of recovery, pacing was initiated at 200 bpm. All animals underwent transthoracic echocardiography every 5 days. The primary end point of significant left ventricular dysfunction was defined prospectively as a fractional shortening Ͻ16% or 2 SDs below the mean fractional shortening in historical controls (32Ϯ8%; nϭ27). Animals were paced until their fractional shortening fell below 16%, at which point they were euthanized.
Cardiomyocyte Isolation and Culture
On development of severe left ventricular dysfunction, animals were euthanized with pentobarbital sodium. The hearts were harvested by left lateral thoracotomy and immersed in ice-cold saline. The region of ventricle perfused by the left anterior descending coronary artery was excised, cannulated, and perfused at 15 mL/min for 10 minutes with nominally Ca 2ϩ -free modified Tyrode's solution (in mmol/L: NaCl 138, KCl 4, MgCl 2 1, NaH 2 PO 4 0.33, glucose 10, and HEPES 10 [pH 7.3 with NaOH] at 37°C and oxygenated with 100% O 2 ). Perfusion was continued with the same solution but containing 0.24% (wt/vol) collagenase type I (Sigma, St Louis, Mo) and 0.028% protease XIV (Sigma) for 12 minutes and then for 10 minutes with washout solution with 0.1 mmol/L CaCl 2 and 0.02% albumin. Sections of well-digested ventricular tissue from the midmyocardial layer of the ventricle were excised, and cells were mechanically dissociated and resuspended in buffers of gradually increasing [Ca 2ϩ ]. To remove dead myocytes and residual contaminating cell types, the myocyte suspension was centrifuged through a discontinuous Percoll gradient, usually resulting in Ͼ90% rod-shaped cells. To allow the myocytes to recover from enzymatic digestion, the cells were cultured overnight at 37°C in serum-free medium 199, supplemented with 5 mmol/L carnitine, 5 mmol/L creatine, 5 mmol/L taurine, 100 g/mL penicillin, 100 units/mL streptomycin, and 0.25 g/mL amphotericin. We have found that this approach increases the rate of successful giga-seal formation without significantly altering phenotype with regard to NCX function and ␤-AR regulation.
Electrophysiology
Whole-cell recordings were obtained at 37°C with the use of standard patch-clamp techniques. Membrane current was assessed by use of an Axopatch-100A amplifier and a 1/100 CV-3 head stage (Axon Instruments). Experimental control, data acquisition, and data analysis were accomplished with the use of the software package Pclamp 8.0 with the Digidata 1200 acquisition system (Axon Instruments). Patch pipettes were pulled from thin-walled glass capillary tubes and heat polished. The electrode resistance ranged from 1 to 2 M⍀. The external solution contained the following (in mmol/L): NaCl 145, MgCl 2 1, HEPES 5, CaCl 2 2, CsCl 5, and glucose 10 (pH 7.4, adjusted with NaOH). Ouabain (0.02 mmol/L) and nifedipine (0.01 mmol/L) were added to the solution. The full scale of ␤-adrenergic stimulation was achieved by addition of isoproterenol (2 mol/L). The internal solution contained the following (in mmol/L): CsCl 65, NaCl 20, Na 2 ATP 5, CaCl 2 6, MgCl 2 4, HEPES 10, tetraethyl ammonium chloride 20, EGTA 21, and ryanodine 0.05 (pH 7.2, adjusted with CsOH). In a separate set of experiments, protein phosphatase type 1 (PP1) (10 U/mL) was added to the internal solution to explore the role of tonic phosphorylation of the NCX in the increased basal I NCX in HF. Membrane currents were elicited with the use of standard voltage ramp protocol. From a holding potential of Ϫ40 mV, a 100-ms step depolarization to ϩ80 mV was followed by a descending voltage ramp (from ϩ80 mV to Ϫ120 mV at 100 mV/s). The protocol was applied every 10 seconds. I NCX was measured as the Ni-sensitive current. Ni 2ϩ (5 mmol/L) was added to define the fraction of current that derives from NCX (the difference between total current and post-Ni 2ϩ current). Membrane capacitance was read directly from the membrane test of Pclamp 8.0 before compensating for series resistance and membrane capacitance.
Identity of the Bidirectional, Ni-Sensitive Current
To test whether our recordings were significantly contaminated by the cAMP-dependent Cl Ϫ current (CFTR) or the Ca-activated Cl Ϫ current, we applied niflumic acid (100 mol/L, Ca-activated Cl Ϫ blocker) and glibenclamide (100 mol/L, CFTR blocker). In separate experiments, we tested whether reducing extracellular Cl Ϫ (from 145 to 8 mmol/L) and whether removing extracellular Ca 2ϩ would rapidly and reversibly suppress the isoproterenol-stimulated current.
Detection and Quantification of the Phosphatases
The total protein from ventricles of normal and failure pig hearts was extracted, and the Western blots were prepared as previously described. 21, 23 The NCX antigen complex NCX antibody/Protein A Sepharose was obtained and prepared for Western blots and then immunoblotted with PP2a antibody (BD Biosciences, San Jose, Calif). After the PP2a in the immunoprecipitated NCX complex was identified, the same nitrocellulose membrane was reprobed with NCX antibody after the membrane was stripped of antibodies from the previous experiment. Similarly, another Western blot membrane was immunoblotted with PP1 antibody (Upstate Cell Signaling Solutions, Charlottesville, Va) and then with NCX antibody. With the use of ECL systems (GE Healthcare, Lake Placid, NY), the results were recorded on Biomax Kodak film. The images in the negative films were scanned and analyzed with the use of ImageQuant software (GE Healthcare Systems). Additionally, the ␤-1, ␤-2, and muscarinic receptor proteins were immunoprecipitated with the use of the appropriate antibody and quantified by Western blot.
Phosphatase Assay
To analyze the total activity of the phosphatases in heart extract and the phosphatases associated with the NCX complex, paranitrophenyl phosphate was used as a substrate, and the measurements were made following the protocol of the Phosphatase Assay Kit (Upstate Cell Signaling Solutions, Lake Placid, NY). Phosphatase activity for the normal and failure heart extracts (each containing 35 g of total protein) was estimated. The phosphatase activity associated with NCX was determined for proteins binding to NCX. The NCX macromolecular complex was obtained by incubating 1.2 L of antibody serum (11) (12) (13) with the concentrated heart extract of 350 L overnight. The NCX complex was washed thoroughly in 800 mL of the wash buffer. 28 Enzyme activity was measured for 10 minutes at 37°C. The absorbance was measured at 405 nm. The phosphatase activity in normal heart was considered to be 100% and was compared with change in HF activity.
Protein Phosphatase Activity of PP1 and PP2a
The phosphatase activity of normal and failure heart extracts was determined with the use of the specific phosphopeptide (KRpTIRR) as a substrate for PP1 and PP2A phosphatase enzymes. The phosphate released was visualized with the use of malachite green following the manufacturer's instructions (Serine/Threonine Phosphatase Assay Kit, Upstate Cell Signaling Solutions, Charlottesville, Va). The solutions were incubated for 20 minutes at room temperature, and color development was measured at 620 nm. The amount of enzyme activity was compared with those measured by the para-nitrophenyl phosphate method.
Statistical Analysis
Data are presented as meanϮSEM. Continuous variables were compared by paired or unpaired t test. A probability value of Ͻ0.05 was regarded as a statistically significant finding.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Identity of the Bidirectional, Ni-Sensitive Current
During the voltage clamp protocol, the membrane potential of the cells was initially held at Ϫ40 mV to inactivate sodium channels. Cells were then depolarized to 80 mV to induce an outward current, as seen in Figure 1A , which reflects 3 Na ϩ flowing outward for 1 Ca 2ϩ inward. The current becomes inward as the cell is hyperpolarized to Ϫ120 mV. The protocol is repeated in the presence of Ni 2ϩ , which blocks the NCX current, and this Ni-insensitive current is subtracted from the initial tracing to yield the Ni-sensitive bidirectional current. The protocol is then repeated in the presence of isoproterenol. If the induced current is indeed due to NCX activity, it should not be sensitive to blockers of Cl Ϫ channels or to the concentration of Cl Ϫ in the bath and pipette but should require the presence of Ca 2ϩ in the bath. Glibenclamide and niflumic acid, blockers of the CFTR and Ca-activated Cl Ϫ currents, respectively, had no effect on the magnitude of the isoproterenol-stimulated, Ni-sensitive current whether given together ( Figure 1B) or separately (not shown). In separate experiments, we found that reducing extracellular chloride (from 145 to 8 mmol/L) had no effect on the magnitude of the isoproterenol-stimulated current ( Figure 1C ), whereas removing Ca 2ϩ rapidly and reversibly suppressed the isoproterenol-stimulated current ( Figure 1D ). Taken together, these data exclude significant contamination by either the CFTR or Ca-activated chloride current and support the identity of the current as NCX. The identity of the Ni-sensitive, bidirectional current is NCX (I NCX ), not Ca-activated chloride current and/or cAMPdependent CFTR current. A, Depiction of the ramp protocol used in the experiments to elicit the current. An example of a raw current tracing is shown in red, then the ramp is repeated in the presence of 5 mmol/L Ni 2ϩ (blue tracing). The green tracing represents the Ni-sensitive component, the difference between the initial tracing and the post-Ni tracing, and is the putative I NCX current. B, From left to right, the average peak outward current density (at ϩ70 mV) elicited in the basal state, in the presence of isoproterenol (ISO) (2 mol/L), and in the presence of isoproterenol with niflumic acid (NIF) (100 mol/L, blocker of Ca-activated chloride current) and glibenclamide (GLI) (100 mol/L, blocker of cAMP-sensitive CFTR current). Niflumic acid and glibenclamide had no effect on the current elicited in the presence of isoproterenol (Pϭ0.96; nϭ4), consistent with absence of significant Ca-activated chloride or CFTR currents contaminating the NCX current after exposure to isoproterenol. C, Representative current tracing of I NCX after lowering external Cl Ϫ from 145 to 8 mmol/L. Lowering Cl Ϫ had no effect on the isoproterenolϩ current (left). The mean peak outward current density (at ϩ70 mV) in the high or low [Cl Ϫ ] o is unchanged (right; Pϭ0.98; nϭ9). D, Representative current tracing of I NCX after removal of Ca 2ϩ . Ca 2ϩ removal rapidly and reversibly suppressed the isoproterenol-induced current (left). The mean peak outward current density in the presence or absence of [Ca 2ϩ ] o (right; *PϽ0.05; nϭ7). These results are inconsistent with CFTR current and support the identity of the current as I NCX .
Blunted ␤-AR and M-2 Regulation of the NCX Current in HF
Recent evidence suggests that ␤-AR stimulation increases NCX activity in mammalian myocytes and that M-2 stimulation can modulate this effect. [17] [18] [19] [20] Figure 2A1 shows a representative tracing of I NCX from control myocytes in basal conditions, in the presence of the ␤-AR agonist isoproterenol (2 mol/L/L), and in the presence of isoproterenol plus the M-2 agonist carbachol (5 mol/L). Isoproterenol markedly increased outward and inward I NCX in control myocytes, and carbachol significantly inhibited the isoproterenol-stimulated effect. The mean population data of peak outward current density (at ϩ70 mV) reveals that isoproterenol increased I NCX Ϸ300% in controls, whereas carbachol almost completely reversed it (PϽ0.01; Figure 2A2 ). However, in failing myocytes basal I NCX was significantly increased compared with control myocytes, whereas isoproterenol manifested blunted stimulation, increasing the peak I NCX to a significantly lesser extent ( Figure 2B2 ). The application of the M-2 agonist carbachol did not result in a significant inhibitory effect on isoproterenol-stimulated I NCX in HF cells ( Figure 2B2 ). This is the first direct evidence of blunted M-2 regulation of the NCX current in HF. Our previous study in a ventricularly paced HF model demonstrated that increased basal I NCX and reduced ␤-AR responsiveness are due to hyperphosphorylation of NCX in HF, but the mechanism of hyperphosphorylation and the interaction with the muscarinic system were not elucidated. Possible explanations for the failure of muscarinic modulation in HF include a decrease in M-2 receptor number, downregulated signal transduction, and/or altered protein phosphorylation state. These alternatives are investigated in the following experiments.
Altered Receptor Number and Downregulated Signal Transduction Are Excluded for Explaining Blunted ␤-〈R and M-2 Regulation of NCX Current in HF
We found no evidence of a reduction in either muscarinic or ␤-adrenergic receptor protein expression in HF, suggesting that receptor number was not changed drastically in our model and pointing to a defect in signal transduction (see online-only Data Supplement). Stimulation of the cardiac muscarinic receptor (mainly M-2) is thought to activate soluble guanylyl cyclase, leading to an increase in intracellular cyclic GMP (cGMP). This increase in cytosolic cGMP could either activate cGMP-dependent protein kinase G (PKG) to phosphorylate effectors or activate a protein phosphatase to dephosphorylate PKA-induced phosphorylation.
To identify the altered steps resulting in blunted ␤-AR and M-2 regulation of I NCX in HF, we exposed failing cells to 8-Br-cAMP and 8-Br-cGMP to directly stimulate PKA and PKG. In control myocytes, cAMP (1 mmol/L) significantly increased I NCX in a manner similar to that of isoproterenol, whereas cGMP significantly reversed this effect; cGMP also reversed the effect of isoproterenol (Figure 3) . In failing myocytes, however, both cGMP effects were blunted, suggesting that the impaired ␤-AR and M-2 regulation is not due to reduced receptor number or uncoupling of the ␤-AR and M-2 signaling pathways. Rather, the defect must be downstream from the generation of cAMP and cGMP. Figure 4A shows that okadaic acid (1 mol/L) significantly reversed the carbachol inhibition of isoproterenol-stimulated NCX current in control myocytes. This result suggests that a protein phosphatase is a crucial component for M-2 regulation of NCX in myocytes and argues for dephosphorylation as opposed to phosphorylation as a mechanism for M-2 modulation of the NCX. Furthermore, if a protein phosphatase is the mediator of M-2 modulation in the control state, it follows that infusion of exogenous protein phosphatase enzyme should reverse isoproterenol stimulation in HF in a manner similar to that of carbachol in the controls. In a separate experiment, dialysis of PP1 (10 U/mL) through the intracellular solution significantly inhibited I NCX in basal and isoproterenol-stimulated conditions in failing myocytes but had no significant effect on basal current in control myocytes ( Figure 4B ). These data suggest that M-2 stimulation inhibits isoproterenol-stimulated Figure 2 . I NCX responsiveness to isoproterenol and carbachol in control and failing myocytes. A1, A representative current tracing of I NCX from a control myocyte in the basal state (blue), after exposure to isoproterenol (2 mol/L, red), and after isoproterenol plus carbachol (5 mol/L, green). Isoproterenol markedly increased outward and inward I NCX , whereas carbachol reversed the increase in I NCX induced by isoproterenol, consistent with "accentuated antagonism." A2, The mean data of peak outward current (at ϩ70 mV; the number of independent experiments is shown in parentheses) as described in A1, confirming that isoproterenol (ISO) significantly increased I NCX (*PϽ0.01, isoproterenol vs basal) and that carbachol (CCH) significantly reversed isoproterenol stimulation (#PϽ0.05, carbachol vs isoproterenol). B, I NCX from failing myocytes (format analogous to that in A). B1, In cells from failing animals, basal I NCX is significantly increased compared with control myocytes, whereas isoproterenol induced a significantly smaller further increase. Unlike in control cells, carbachol had no effect on the isoproterenol-stimulated current, demonstrating failure of muscarinic-accentuated antagonism. B2, The mean data of peak outward current (at ϩ70 mV; the number of independent experiments is shown in parentheses) in myocytes from failing animals as described in B1, confirming the failure of carbachol to reverse the effect of isoproterenol. *PϽ0.01.
Muscarinic System Antagonizes ␤-AR Stimulation via Protein Phosphatase
I NCX through activation of a protein phosphatase and that excessive protein phosphorylation in HF results in both increased basal activity and decreased ␤-AR responsiveness. A unifying hypothesis explaining these phenomena, as well as the failure of the NCX to respond to M-2 stimulation in HF, would be that the protein phosphatase associated with the NCX is significantly downregulated or inhibited in HF. To test this hypothesis, we measured protein phosphatase levels and activity in protein precipitated with the NCX complex.
Protein Phosphatases Associated With NCX in HF
To test whether the protein phosphatases associated with the NCX are decreased in HF, we examined PP1-and PP2a-associated NCX with a specific antibody directed against PP1 and PP2a in NCX proteins immunoprecipitated by NCX antibody. The NCX proteins were immunoprecipitated by NCX antibody from control and failing heart tissues. The proteins in the NCX complex were separated with the use of PAGE and transferred to nitrocellulose membranes. These membranes were immunoblotted with PP2a antibodies, and the same blot was reprobed with NCX antibody after the membrane was stripped of antibodies from a previous experiment. Figure 5A is a representative Western blot of PP1 and PP2a in control and failing heart samples, showing that PP1 protein is significantly reduced in HF. Surprisingly, PP2a expression appears significantly increased in failing heart muscle compared with control in absolute terms ( Figure 5B; PϽ0.05). However, the total amount of NCX protein was increased in failing hearts by Ϸ40% (Figure 5B ; PϽ0.05). After normalization for the amount of NCX protein from control and failing hearts, group analysis confirmed that the mean amount of PP1 in failing hearts was 33% that in control hearts (PϽ0.01), but PP2a levels were not altered with respect to NCX. To test whether this relative shift in protein expression would alter phosphatase activity, we assessed protein phosphatase activity associated with the NCX and in bulk myocardium with para-nitrophenyl phosphate and malachite green methods. Protein phosphatase activity associated with the NCX was significantly depressed in failing heart compared with control, but no significant difference existed between protein phosphatase activity in bulk myocardium between failure and control states ( Figure 6 ). These results provide direct evidence that protein phosphatase activity associated with the NCX is downregulated in HF.
Discussion
This is the first study to investigate the interaction of ␤-AR and M-2 regulation of the NCX in HF. The principal findings are as follows: (1) muscarinic receptor stimulation in control 
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myocytes significantly reverses ␤-AR stimulation of the NCX via activation of a protein phosphatase; (2) in HF, the NCX is "locked" in a relatively high activity state and is insensitive to both ␤-AR and M-2 regulation; (3) the common pathway of these alterations is downregulated protein phosphatase activity resulting in defective NCX dephosphorylation in HF; and (4) the profile of protein phosphatases associated with the NCX is significantly changed in HF with a reduction in PP1 but no change in PP2a. These results extend our previous findings that HF results in hyperphosphorylation of the NCX by providing a mechanism for an increased phosphorylation state, and they further explore the impact of this phenomenon on the autonomic modulation of the exchanger. Furthermore, the use of atrially paced animals addresses the concern that NCX hyperphosphorylation may represent an epiphenomenon of ventricular pacing.
Modulation of the NCX by the ␤-AR and Muscarinic Systems
Controversy exists regarding whether the cardiac NCX is modulated by PKA. 29, 30 The cAMP-dependent Cl Ϫ current (CFTR) and the Ca-activated Cl Ϫ current are reported to be Ni 2ϩ sensitive and have reversal potentials similar to those of NCX. 31 Lin et al 32 have suggested that these conductances could contaminate our recordings of NCX, especially during stimulation of the ␤-AR, causing an overestimation of the effect of isoproterenol on the NCX. In the present study, we found no effect of significantly reducing extracellular chloride on the bidirectional, Ni 2ϩ -sensitive current in pig ventricular myocytes. Additionally, we found that the current was Ca 2ϩ dependent, which is consistent with the NCX but not CFTR. Our result is consistent with other reports that although the CFTR conductance is highly represented in small animals, it is nearly or Figure 5 . Identification and quantification of protein phosphatases associated with NCX protein. The NCX macromolecular complex was immunoprecipitated from normal and failure heart extracts with the use of NCX antibody and Protein A Sepharose beads. The proteins in the NCX complex were separated with the use of PAGE and transferred to nitrocellulose membranes. These membranes were immunoblotted with PP2a antibodies, and the same blot was reprobed with NCX antibody after the membrane was stripped of antibodies from a previous experiment. A shows PP1 protein (top) in the complex immunoprecipitated by NCX antibody, PP2a (middle), and the NCX protein itself in the complex (bottom) in representative control (C) and HF (F) animals. B, The top panel shows the average amount of PP1 protein (ϮSEM) associated with the NCX complex from 6 HF and 5 normal animals. There was significant reduction of PP1 enzyme associated with NCX in HF (**PϽ0.01). There was a slight (but significant, *PϽ0.05) increase in the PP2a enzyme amount associated with NCX in the HF compared with normal hearts (middle). NCX protein (bottom) measured by Western blot was modestly but significantly increased in HF hearts compared with controls (PϽ0.05).
completely absent in large animals such as dogs or humans. 33 Further underscoring the significance of interspecies differences, Ginsburg and Bers 34 found no evidence of isoproterenol stimulation of NCX in meticulously controlled experiments in nonfailing rabbits. Although we have no experience with this model, one wonders whether differences in phosphatase activity may account for differences in response to isoproterenol; in such a case, an alternative approach using a phosphatase inhibitor might have yielded evidence of NCX augmentation. Our findings, furthermore, are consistent with those of other groups who found significant increases in NCX current after stimulation with isoproterenol. 17, 18, 20 The exchanger has been reported to be associated with the regulatory R-1 complex comprising PKA, AKAP, PP1, protein kinase C, and PP2a, 21 an important piece of evidence suggesting autonomic regulation. Nevertheless, the PKA phosphorylation site on the exchanger has not been identified. The rat cardiac NCX1 sequence presents 5 probable sites, of which 3 are intracellular (threonine at 74 and 618; serine at 389). Methodological differences in the assessment of NCX activity may also contribute to conflicting results. Caffeine superfusion during voltage clamp is a time-honored alternative method of detecting and quantifying the exchange current, but for purposes of studying changes induced by phosphorylation of the exchanger, the ramp method may be superior because it should be less sensitive to changes in sarco/endoplasmic reticular Ca 2ϩ -ATPase function and sarcoplasmic reticular calcium load.
Further evidence that the NCX is regulated by the autonomic nervous system in a manner that is relevant to human disease is accumulating. Although stimulation of the M-2 receptor by carbachol in the absence of preceding ␤-AR stimulation has been shown to induce an indirect increase in the NCX current via subsarcolemmal Na ϩ gain, 35 the present study confirms the observations of Zhang et al 20 that NCX activity is strongly depressed by muscarinic agonists administered during ␤-AR stimulation, but the mechanism of signal transduction was not previously elucidated. Investigating the L-type Ca channel, Jiang et al 36 reported that M-2 modulates ␤-AR stimulation via PKG-induced L-type channel phosphorylation, whereas Shen and Pappano 37 have suggested that the primary response of cGMP is to activate protein phosphatases to dephosphorylate PKA-induced phosphorylation. To examine these putative mechanisms, we reasoned that if the muscarinic effect is modulated by phosphorylation of a separate site on the NCX in the presence of isoproterenol, then application of a nonspecific protein phosphatase inhibitor, ie, okadaic acid, should increase (or at least not inhibit) muscarinic modulation of the current by allowing further accumulation of phosphorylation. Alternatively, if M-2 stimulation results in activation of an NCX-associated protein phosphatase, inhibition of that phosphatase by okadaic acid should reverse the effect of M-2 stimulation and restore the current. We found that okadaic acid indeed reversed the carbachol effect, consistent with activation of a phosphatase as the mechanism of muscarinic modulation of the NCX. Finally, Katanosaka et al 38 have reported that the C-terminus of the A␤ of calcineurin, a phosphatase mechanistically implicated in cardiac hypertrophy, binds to the cytoplasmic loop of the cardiac NCX in hamsters. Prolonged phenylephrine exposure, which would stimulate the ␣-adrenergic system and act as a model of hypertension, resulted in inhibition of Na efflux from isolated myocytes in a manner that was prevented by inhibition by calcineurin. This is consistent with differential phosphatase modulation by distinct pathological signaling mechanisms.
Blunted ␤-〈R and M-2 Regulation in HF
Recent studies have suggested that elevated tonic phosphorylation (hyperphosphorylation) of calcium handling proteins such as the L-type Ca channel and the ryanodine receptor might contribute to increased basal Ca 2ϩ permeability and reduced responsiveness to ␤-AR stimulation. In our previous study, we also found that the NCX is hyperphosphorylated in HF, suggesting that downregulated protein phosphatase might be the underlying mechanism. In the present study, we have demonstrated reduced PP1 protein and protein phosphatase activity associated with the NCX, providing a mechanism for NCX hyperphosphorylation in HF. The present study differs somewhat from our previous work in that these animals were atrially paced into HF. This change should avoid artifactual changes in myocyte phenotype due to abnormal depolarization; Figure 6 . Protein phosphatase activity in normal and failing hearts. The protein phosphatase activity associated with NCX protein complex and in the heart extract was determined with the use of para-nitrophenyl phosphate and phosphopeptide (KRpTIRR) as substrates. A, The amount of general phosphatase activity was reduced in the NCX complex-associated phosphatases (nϭ6; *PϽ0.01), but the activity was not significantly different in the heart extracts in HF compared with control pigs. B, The serine/threonine phosphatase activity associated with the NCX was also significantly reduced in HF animals compared with controls (C).
however, the magnitude of the increase in the basal current due to HF appears to be 25% less than we found previously despite similar increases in NCX expression. The most likely explanation is that rapid ventricular pacing induces a more severe HF phenotype because of the introduction of intraventricular and atrioventricular dyssynchrony that would not be appreciated by echocardiograms performed in sinus rhythm.
In the present study, we found that the M-2 receptor agonist carbachol loses its ability to inhibit ␤-AR stimulation on the NCX in HF. In contrast to the decreased numbers of ␤-AR receptors found in HF, the number of M-2 receptors is either unchanged or increased in HF. 39 We found that application of cGMP fails to recover M-2 inhibition of ␤-AR signaling, confirming that the defect of muscarinic regulation is not at the M-2 receptor and/or G i protein and must be downstream of cGMP. However, dialysis with PP1 significantly depressed both NCX current in basal conditions and after isoproterenol stimulation in HF. Furthermore, the protein phosphatase inhibitor okadaic acid eliminates carbachol inhibition of isoproterenol-stimulated I NCX , indicating that M-2 regulation of the NCX is dependent on protein phosphatase activity. On the basis of these findings, we suggest that both ␤-AR and M-2 dysfunction in HF are due to downregulation of protein phosphatase, principally PP1.
Downregulated Protein Phosphatase Associated With NCX in HF
The effect of HF on protein phosphatase expression and activity is clearly complex. Neumann et al 40 have reported that cardiac PP1 protein and mRNA levels were increased in HF, resulting in decreased phospholamban phosphorylation and depressed sarcoplasmic reticulum-ATPase function, whereas other groups have found decreased local protein phosphatase expression. Marx et al 14 found that the protein levels of both PP1 and PP2a associated with ryanodine receptor were reduced in HF. In the present study, we found that the NCX associates with protein phosphatases in a macromolecular complex in pig hearts, similar to findings in the rat. In contrast to the results of Marx et al (with respect to the ryanodine receptor), however, we found that PP1 expression is decreased, whereas PP2a associated with the NCX is unchanged in HF. Despite this shift in phosphatase profile associated with the complex, we found that total protein phosphatase activity associated with NCX is significantly depressed in HF compared with control (whereas total myocardial activity is unchanged). These results suggest that PP1 might play a principal role in NCX dephosphorylation in the control state, whereas PP2a is predominant in HF. Although it is generally believed that PP1 and PP2a have similar activity in terms of dephosphorylation of serine/threonine sites, the structure, activity, and regulation of these isoforms are distinct. 41, 42 PP1 activity is modulated by the inhibitor protein I-1, which is itself activated by PKA phosphorylation. PP2a can dephosphorylate I-1, 43 but little is known about the regulation of PP2a itself. A recent report has suggested that the enzyme is inhibited by elevated [Ca 2ϩ ] I , 44 whereas overexpression of PP2a has been shown to result in reduce cardiac contractility. 45 The present study suggests that PP2a activity is not modulated by muscarinic stimulation, resulting in failure of dephosphorylation of the NCX in response to M-2 stimulation. The effect of this shift in phosphatase isoform expression on NCX regulation and the HF phenotype merits further investigation.
Conclusions
Fifty percent of the deaths in patients with HF are sudden and presumably arrhythmic. Increased NCX activity in HF is likely to enhance depolarizing current, particularly when associated with spontaneous calcium release from the sarcoplasmic reticulum, which could result in afterdepolarizations triggering fatal ventricular arrhythmia. Furthermore, excess NCX activity has been tied to depression of the systolic calcium transient in HF, linking the NCX to mechanical pump dysfunction as well. The present study shows that in HF, the NCX is "locked" in a relatively high activity state and insensitive to both ␤-AR and M-2 regulation, which could reduce cardiac contractile reserve and increase susceptibility to arrhythmia. The common pathway of these alterations is downregulation of associated protein phosphatase activity, resulting in defective NCX dephosphorylation in HF. Dephosphorylation of the NCX represents a possible therapeutic target for reducing arrhythmia and pump dysfunction in HF.
